{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:23:36Z","timestamp":1783002216345,"version":"3.54.5"},"reference-count":28,"publisher":"National Academy of Sciences","issue":"26","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[1998,12,22]]},"abstract":"<jats:p>\n                    The epothilones are naturally occurring, cytotoxic macrolides that function through a paclitaxel (Taxol)-like mechanism. Although structurally dissimilar, both classes of molecules lead to the arrest of cell division and eventual cell death by stabilizing cellular microtubule assemblies. The epothilones differ in their ability to retain activity against multidrug-resistant (MDR) cell lines and tumors where paclitaxel fails. In the current account, we focus on the relationship between epothilone and paclitaxel in the context of tumors with multiple drug resistance. The epothilone analogue\n                    <jats:italic>Z<\/jats:italic>\n                    -12,13-desoxyepothilone B (dEpoB) is &gt;35,000-fold more potent than paclitaxel in inhibiting cell growth in the MDR DC-3F\/ADX cell line. Various formulations, routes, and schedules of i.v. administration of dEpoB have been tested in nude mice. Slow infusion with a Cremophor-ethanol vehicle proved to be the most beneficial in increasing efficacy and decreasing toxicity. Although dEpoB performed similarly to paclitaxel in sensitive tumors xenografts (MX-1 human mammary and HT-29 colon tumor), its effects were clearly superior against MDR tumors. When dEpoB was administered to nude mice bearing our MDR human lymphoblastic T cell leukemia (CCRF-CEM\/paclitaxel), dEpoB demonstrated a full curative effect. For human mammary adenocarcinoma MCF-7\/Adr cells refractory to paclitaxel, dEpoB reduced the established tumors, markedly suppressed tumor growth, and surpassed other commonly used chemotherapy drugs such as adriamycin, vinblastine, and etoposide in beneficial effects.\n                  <\/jats:p>","DOI":"10.1073\/pnas.95.26.15798","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:40:11Z","timestamp":1027680011000},"page":"15798-15802","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":145,"title":["Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel"],"prefix":"10.1073","volume":"95","author":[{"given":"Ting-Chao","family":"Chou","sequence":"first","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Guo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Harris","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Kuduk","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Balog","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Savin","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Bertino","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Danishefsky","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Therapeutics Program, and Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10021; and Cornell University Graduate School of Medical Sciences, 1275 York Avenue, New York, NY 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[1998,12,22]]},"reference":[{"key":"e_1_3_3_1_2","volume-title":"The Chemistry and Pharmacology of Taxol and Its Derivatives","author":"Landino L M","year":"1995","unstructured":"L M Landino, T L MacDonald The Chemistry and Pharmacology of Taxol and Its Derivatives, ed V Favin (Elsevier, New York, Chap. 7. (1995)."},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.27.17118"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199208000-00001"},{"key":"e_1_3_3_4_2","first-page":"1","volume":"20","author":"Rowinsky E K","year":"1993","unstructured":"E K Rowinsky, E A Eisenhauer, V Chaudhry, S G Arbuck, R C Donehower Semin Oncol 20, 1\u201315 (1993).","journal-title":"Semin Oncol"},{"key":"e_1_3_3_5_2","first-page":"31","volume":"28","author":"Ojima I","year":"1998","unstructured":"I Ojima, P-Y Bounaud, R J Bernacki CHEMTECH 28, 31\u201336 (1998).","journal-title":"CHEMTECH"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199720931"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/277665a0"},{"key":"e_1_3_3_8_2","first-page":"2325","volume":"55","author":"Bollag D M","year":"1995","unstructured":"D M Bollag, P A McQuency, J Zhu, O Hensens, L Koupal, J Liesch, M Goetz, E Lazarides, C M Woods Cancer Res 55, 2325\u20132333 (1995).","journal-title":"Cancer Res"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.4.2534"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199615671"},{"key":"e_1_3_3_11_2","first-page":"3344","volume":"57","author":"Muhlradt P F","year":"1997","unstructured":"P F Muhlradt, F Sasse Cancer Res 57, 3344\u20133346 (1997).","journal-title":"Cancer Res"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5295.2009"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199628011"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199707571"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/387268a0"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199701661"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199705231"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja964275j"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja971946k"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3773(19981016)37:19<2675::AID-ANIE2675>3.0.CO;2-O"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9642"},{"key":"e_1_3_3_22_2","first-page":"163","volume":"39","author":"Chou T-C","year":"1998","unstructured":"T-C Chou, X-G Zhang, S J Danishefsky Proc Am Assoc Cancer Res 39, 163\u2013164 (1998).","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(81)90027-X"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.13.1107"},{"key":"e_1_3_3_25_2","first-page":"4827","volume":"48","author":"Scudiero D A","year":"1988","unstructured":"D A Scudiero, R H Shoemaker, K D Paull, A Monks, S Tierney, T H Nofziger, M J Currens, D Seniff, M R Boyd Cancer Res 48, 4827\u20134833 (1988).","journal-title":"Cancer Res"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(84)90007-4"},{"key":"e_1_3_3_27_2","volume-title":"Dose-Effect Analysis with Microcomputers: Quantitation of ED50, Synergism, Antagonism, Low-Dose Risk, Reception-Rigand Binding and Enzyme Kinetics, IBM-PC software and manual","author":"Chou J","year":"1987","unstructured":"J Chou, T-C Chou Dose-Effect Analysis with Microcomputers: Quantitation of ED50, Synergism, Antagonism, Low-Dose Risk, Reception-Rigand Binding and Enzyme Kinetics, IBM-PC software and manual (Biosoft, Cambridge, U. K., 1987)."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.95.26.15798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T16:13:06Z","timestamp":1649866386000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.95.26.15798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12,22]]},"references-count":28,"journal-issue":{"issue":"26","published-print":{"date-parts":[[1998,12,22]]}},"alternative-id":["10.1073\/pnas.95.26.15798"],"URL":"https:\/\/doi.org\/10.1073\/pnas.95.26.15798","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12,22]]},"assertion":[{"value":"1998-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}